1. Home
  2. BX vs BSX Comparison

BX vs BSX Comparison

Compare BX & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Inc.

BX

Blackstone Inc.

HOLD

Current Price

$155.93

Market Cap

132.8B

Sector

Finance

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$92.51

Market Cap

149.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BX
BSX
Founded
1985
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.8B
149.7B
IPO Year
2007
1992

Fundamental Metrics

Financial Performance
Metric
BX
BSX
Price
$155.93
$92.51
Analyst Decision
Buy
Strong Buy
Analyst Count
16
19
Target Price
$177.81
$124.53
AVG Volume (30 Days)
4.2M
9.5M
Earning Date
01-29-2026
10-22-2025
Dividend Yield
2.53%
N/A
EPS Growth
19.48
54.68
EPS
3.48
1.87
Revenue
$12,791,218,000.00
$19,349,000,000.00
Revenue This Year
$4.00
$21.05
Revenue Next Year
$25.64
$11.43
P/E Ratio
$44.84
$49.48
Revenue Growth
14.84
21.61
52 Week Low
$115.66
$85.98
52 Week High
$194.00
$109.50

Technical Indicators

Market Signals
Indicator
BX
BSX
Relative Strength Index (RSI) 65.13 30.97
Support Level $143.21 $100.50
Resistance Level $153.82 $101.91
Average True Range (ATR) 3.61 2.23
MACD 2.05 -0.76
Stochastic Oscillator 91.27 2.54

Price Performance

Historical Comparison
BX
BSX

About BX Blackstone Inc.

Blackstone is the world's largest alternative-asset manager with $1.167 trillion in total asset under management, including $860.1 billion in fee-earning assets under management, at the end of March 2025. The company has four core business segments: private equity (26% of fee-earning AUM and 30% of base management fees), real estate (34% and 40%), credit and insurance (32% and 23%), and multi-asset investing (8% and 7%). While the firm primarily serves institutional investors (87% of AUM), it also caters to clients in the high-net-worth channel (13%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: